Advertisement
Screener

VivoSim Labs, Inc. (VIVS) Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net

1.8 / 5 stars · 31/86 Roast Me

VivoSim Labs, Inc. Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net

VivoSim Labs, Inc. (VIVS) reported Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net of $0 for the 12-month period ending 2018-03-31, per its 10-K filed 2018-05-31.

Discontinued › Income Statement › Other Income

us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet · last filed 2018-05-31

  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2017-09-30 was $0.00.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for the quarter ending 2017-06-30 was $0.00.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2017 was $4.00K.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2016 was -$17.00K, a 108.67% decline from fiscal 2015.
  • VivoSim Labs, Inc. derivative instruments not designated as hedging instruments, gain (loss), net for fiscal 2015 was $196.00K.
Period endDerivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 3 monthDerivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 6 monthDerivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 9 monthDerivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net 12 month
2018-03-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31
$0.00
derived: sum of 2 quarters · filed 2018-05-31
$0.00
derived: sum of 3 quarters · filed 2018-05-31
$0.00
10-K · filed 2018-05-31
2017-12-31$0.00
10-Q · filed 2018-02-08
$0.00
derived: sum of 2 quarters · filed 2018-02-08
$0.00
10-Q · filed 2018-02-08
$8.00K
derived: sum of 4 quarters · filed 2018-05-31
2017-09-30$0.00
10-Q · filed 2017-11-09
$0.00
10-Q · filed 2017-11-09
$8.00K
derived: sum of 3 quarters · filed 2018-05-31
$9.00K
derived: sum of 4 quarters · filed 2018-05-31
2017-06-30$0.00
10-Q · filed 2017-08-09
$8.00K
derived: sum of 2 quarters · filed 2018-05-31
$9.00K
derived: sum of 3 quarters · filed 2018-05-31
$9.00K
derived: sum of 4 quarters · filed 2018-05-31
2017-03-31$8.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31
$9.00K
derived: sum of 2 quarters · filed 2018-05-31
$9.00K
derived: sum of 3 quarters · filed 2018-05-31
$4.00K
10-K · filed 2018-05-31
2016-12-31$1.00K
10-Q · filed 2018-02-08
$1.00K
derived: sum of 2 quarters · filed 2018-02-08
-$4.00K
10-Q · filed 2018-02-08
$6.00K
derived: sum of 4 quarters · filed 2018-05-31
2016-09-30$0.00
10-Q · filed 2017-11-09
-$5.00K
10-Q · filed 2017-11-09
$5.00K
derived: sum of 3 quarters · filed 2018-05-31
$7.00K
derived: sum of 4 quarters · filed 2018-05-31
2016-06-30-$5.00K
10-Q · filed 2017-08-09
$5.00K
derived: sum of 2 quarters · filed 2018-05-31
$7.00K
derived: sum of 3 quarters · filed 2018-05-31
$16.00K
derived: sum of 4 quarters · filed 2018-05-31
2016-03-31$10.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31
$12.00K
derived: sum of 2 quarters · filed 2018-05-31
$21.00K
derived: sum of 3 quarters · filed 2018-05-31
-$17.00K
10-K · filed 2018-05-31
2015-12-31$2.00K
10-Q · filed 2017-02-09
$11.00K
derived: sum of 2 quarters · filed 2017-02-09
-$27.00K
10-Q · filed 2017-02-09
$145.00K
derived: sum of 4 quarters · filed 2017-06-07
2015-09-30$9.00K
10-Q · filed 2016-11-03
-$28.00K
10-Q · filed 2016-11-03
$143.00K
derived: sum of 3 quarters · filed 2017-06-07
$103.00K
derived: sum of 4 quarters · filed 2017-06-07
2015-06-30-$38.00K
10-Q · filed 2016-08-04
$134.00K
derived: sum of 2 quarters · filed 2017-06-07
$94.00K
derived: sum of 3 quarters · filed 2017-06-07
$188.00K
derived: sum of 4 quarters · filed 2017-06-07
2015-03-31$172.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07
$132.00K
derived: sum of 2 quarters · filed 2017-06-07
$226.00K
derived: sum of 3 quarters · filed 2017-06-07
$196.00K
10-K · filed 2017-06-07
2014-12-31-$40.00K
10-Q · filed 2016-02-08
$54.00K
derived: sum of 2 quarters · filed 2016-02-08
$24.00K
10-Q · filed 2016-02-08
2014-09-30$94.00K
10-Q · filed 2015-11-09
$64.00K
10-Q · filed 2015-11-09
2014-06-30-$30.00K
10-Q · filed 2015-08-10
2014-03-31-$5.12M
10-K · filed 2016-06-09
2013-03-31-$12.03M
10-K · filed 2015-06-09
2012-12-31-$9.93M
10-K · filed 2015-06-09
2012-03-31-$13.51M
10-K · filed 2015-06-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
Silexion Therapeutics Corp (SLXN)$0.001B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70